Interestingly, a search for human homologs allowed the characterization of a BCL9/9L-KO signature of 378 genes that was then used to probe public human CRC databases revealing that hazards of relapse and death are both significantly reduced in patients displaying BCL9/9L-KO-like tumor profiles. Here, BCL9 is linked to neoplasm.